Menu

Category: Federal

GOP Scrutinizes Medicare Price Negotiations in House Subcommittee Hearing

William Newton Washington Correspondent Views
Rep. Cathy McMorris Rodgers (R-Wash.), chair of the E&C Committee, and other Republican committee members criticized Medicare price negotiations in an oversight hearing this week.
Republicans and Democrats battled over Medicare price negotiation provisions under the Inflation Reduction Act (IRA) during a contentious Sept. 20 [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

House Subcommittee to Examine GOP Drug Shortages Bill with 340B Provisions

William Newton Washington Correspondent Views
House Committee on E&C wall plaque
The House Energy & Commerce Health Subcommittee will review a draft drug shortages bill with 340B program implications.
A Sept. 14 House subcommittee hearing will review draft legislation, which would exclude certain generic drugs from the 340B program [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Coming Major GOP Healthcare Package Includes 340B Medicaid Provisions

Rich Daly Editor in Chief Views
A GOP bill expected to be introduced in the U.S. House contains provisions on Medicaid managed care 340B payments.
Republican House leaders were expected introduce—as soon as Sept. 8—and quickly advance a combined package of healthcare bills that includes [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Little Chance Congress Clears 340B Overhaul in 2023—Unless Courts Act, Say Lobbyists

Rich Daly Editor in Chief Views
Capitol building
Lobbyists say Congress is unlikely to clear any major reform of the 340B in the remaining months of 2023 in the absence of a major court decision.
Congress is unlikely to clear any major reform of the 340B in the remaining months of 2023, unless spurred by [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Boehringer Ingelheim Sues to Block Medicare Price Negotiations

William Newton Washington Correspondent Views
Boehringer Ingelheim headquarters
Boehringer Ingelheim sued the federal government to block Medicare price negotiations shortly before its diabetes drug was picked for negotiations.
Drug maker Boehringer Ingelheim (BI) sued the federal government to block Medicare price negotiations shortly before the Department of Health [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

Lawmaker Sponsoring 340B Transparency Bill Honored by PhRMA-Provider Group

Rich Daly Editor in Chief Views
Buschon ASAP 340B award
Rep. Larry Bucshon (R-Indiana) received the "Saving America’s 340B Program Leadership Award" award from ASAP 340B.
The congressional sponsor of legislation that would require hospitals and potentially other covered entities to publicly report their 340B revenue, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

HHS Announces First 10 Drugs Eligible for Medicare Price Negotiations

William Newton Washington Correspondent Views
CMS headquarters
CMS issued the final rule to implement a $9 billion lump sum payment to 340B hospitals for previous illegal cuts between 2018 and 2021.
The Department of Health and Human Services (HHS) today announced the first 10 prescription drugs eligible for Medicare price negotiations [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

AHA Urges Dropping Bill Language to Exclude Generic Injectables from 340B

Rich Daly Editor in Chief Views
American Hospital Association logo
The American Hospital Association opposed parts of draft legislation from the House E&C Committee concerning the 340B program.
The nation’s largest hospital advocacy organization urged legislators to drop a provision from draft legislation that would exclude generic injectables [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »

340B Lobbying Activity Experiences Historic Surge

Rich Daly Editor in Chief Views
Capitol building
Lobbyists say Congress is unlikely to clear any major reform of the 340B in the remaining months of 2023 in the absence of a major court decision.
The hiring of lobbyists in the congressional legislative fight over 340B was dominated by pharmaceutical firms and provider-manufacturer alliances in [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
…
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report